Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

COVID-19 Update:Learn more about how we are protecting our patients, families and staff, as well as other important facts about COVID-19.

2022

Children’s National Hospital trial shows bionic pancreas improves Type 1 diabetes management compared to standard insulin delivery methods

A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose levels within normal range than standard-of-care management among people with Type 1 diabetes, a new  multicenter clinical trial has found. The trial, conducted partly at Children’s National Hospital was primarily funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, and published in the New England Journal of Medicine.

New clues into how the circadian clock helps the brain recover after injury

A type of brain cell that can renew itself is regulated by circadian rhythms, providing significant insights into how the body’s internal clock may promote healing after traumatic brain injuries (TBI), according to new research from Children’s National Hospital. Released in the latest issue of eNeuro, the findings open new avenues of investigation for future TBI therapies.
A girl sits at a table holding her head in one hand while she looks at a laptop computer.

Children's headaches and mental health worsened during pandemic

Since the beginning of the COVID-19 pandemic, many pediatric patients who suffer from headaches have experienced more frequent headaches and worsening anxiety and mood, and a new study finds links to stress, decreased physical activity and increased screen time.

Prestigious annual pediatric medical device competition reveals five finalists

Representing innovations in pediatric technologies that aim to address unmet medical needs for children, these five finalists now have access to a pediatric accelerator program led by MedTech Innovator and will compete for a share of $150,000 in grant funding from the U.S. Food and Drug Administration (FDA) in the final virtual pitch event in October 2022.